The National Center for Advancing Translational Sciences (NCATS) and the National Institute of Allergy and Infectious Diseases (NIAID) are co-hosting this scientific summit to discuss progress and remaining challenges in developing antiviral treatments for COVID-19.
Scientific experts from public and private sectors will examine such topics as SARS-CoV-2 targets for drug development and tools to test promising antiviral drug candidates. They also will identify unmet research needs, share lessons learned from other infectious diseases and explore opportunities for public-private partnerships. The summit opens with remarks from NIH Director Francis S. Collins, MD, PhD; NIAID Director Anthony S. Fauci, MD, and NCATS Director Christopher P. Austin, MD.
The meeting can be viewed live or on demand. Registration is not required.